These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30420515)

  • 1. PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice.
    Katafuchi T; Holland WL; Kollipara RK; Kittler R; Mangelsdorf DJ; Kliewer SA
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12102-12111. PubMed ID: 30420515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats.
    Lim S; Ahn BY; Chung SS; Park HS; Cho BJ; Kim M; Choi SH; Lee IK; Lee SW; Choi SJ; Chung CH; Cho YM; Lee HK; Park KS
    Atherosclerosis; 2009 Oct; 206(2):411-7. PubMed ID: 19339015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation.
    Floyd ZE; Stephens JM
    Obes Res; 2004 Jun; 12(6):921-8. PubMed ID: 15229330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.
    Floyd ZE; Stephens JM
    Biochim Biophys Acta; 2012 Jul; 1822(7):1090-5. PubMed ID: 22504298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
    Takasawa K; Kubota N; Terauchi Y; Kadowaki T
    Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1.
    Wang Q; Tang J; Jiang S; Huang Z; Song A; Hou S; Gao X; Ruan HB
    J Endocrinol; 2018 Nov; 239(2):167-180. PubMed ID: 30121577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes.
    Chung SS; Ahn BY; Kim M; Kho JH; Jung HS; Park KS
    Biochem J; 2011 Jan; 433(1):155-61. PubMed ID: 20950277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.
    Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N
    Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.
    Lee SM; Muratalla J; Diaz-Ruiz A; Remon-Ruiz P; McCann M; Liew CW; Kineman RD; Cordoba-Chacon J
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34417811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice.
    Coelho MS; de Lima CL; Royer C; Silva JB; Oliveira FC; Christ CG; Pereira SA; Bao SN; Lima MC; Pitta MG; Pitta IR; Neves FA; Amato AA
    PLoS One; 2016; 11(5):e0154310. PubMed ID: 27138164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity.
    Li P; Song Y; Zan W; Qin L; Han S; Jiang B; Dou H; Shao C; Gong Y
    Diabetes; 2017 Feb; 66(2):300-313. PubMed ID: 27899484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain.
    Yamashita D; Yamaguchi T; Shimizu M; Nakata N; Hirose F; Osumi T
    Genes Cells; 2004 Nov; 9(11):1017-29. PubMed ID: 15507114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
    Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding reduces SUMOylation of the peroxisome proliferator-activated receptor γ (PPARγ) activation function 1 (AF1) domain.
    Diezko R; Suske G
    PLoS One; 2013; 8(6):e66947. PubMed ID: 23826177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation.
    Shimizu M; Yamashita D; Yamaguchi T; Hirose F; Osumi T
    Mol Cell Biochem; 2006 Jun; 286(1-2):33-42. PubMed ID: 16534556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PPARγ-Bnip3 Axis Couples Adipose Mitochondrial Fusion-Fission Balance to Systemic Insulin Sensitivity.
    Tol MJ; Ottenhoff R; van Eijk M; Zelcer N; Aten J; Houten SM; Geerts D; van Roomen C; Bierlaagh MC; Scheij S; Hoeksema MA; Aerts JM; Bogan JS; Dorn GW; Argmann CA; Verhoeven AJ
    Diabetes; 2016 Sep; 65(9):2591-605. PubMed ID: 27325287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO-1 regulates body weight and adipogenesis via PPARγ in male and female mice.
    Mikkonen L; Hirvonen J; Jänne OA
    Endocrinology; 2013 Feb; 154(2):698-708. PubMed ID: 23270804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of eNOS-NO signaling by over-SUMOylation of PPARγ contributes to insulin resistance and dysfunction of vascular endothelium in rats.
    Yuan W; Ma C; Zhou Y; Wang M; Zeng G; Huang Q
    Vascul Pharmacol; 2019; 122-123():106597. PubMed ID: 31479752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.